Cardiovascular Renal Metabolic

AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
BMI Affects NT-proBNP Risk Stratification in HFpEF

Radcliffe Cardiology

AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s

Nicolas M Van Mieghem

Watch time: 14m 12s (23 videos)

Mohammed El-Sheikh, Nora Olsen El Caidi, Aginsha Kandiah, et al

Read time: 24m 35s

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
EASD 25: EMPIRE-PREVENT: Metabolic Effects of Empagliflozin in Patients at Risk of Heart Failure

Camilla Andersen

Watch time: 6m 28s
Obesity in Focus: Implications for Heart Failure, Kidney Disease, and Pharmacology

Chim C Lang, Bianca Rocca, Samira Bell, et al

Watch time: 14m 14s
High-Dose Flu Vaccine Linked to Reduced Cardiovascular Hospitalisations in Older Adults

Radcliffe Cardiology

FDA Approves Finerenone for Heart Failure with LVEF ≥40%

Radcliffe Cardiology

Andrew JS Coats, Stefan Anker

Nicolas M Van Mieghem

Watch time: 14m 12s (23 videos)

Shubh K Patel, Hwee Teoh, Ahreni Saunthar, et al

Read time: 24m 34s

Dinesh Khullar, Anish Kumar Gupta, Kulwant Singh

Read time: 21m 40s

Giulio Balestrieri, Raul Limonta, Enrico Ponti, et al

Read time: 18m 10s
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
EP 87: Gut Microbiome and Heart Health: The 3 Compounds You Need to Know About with Dr Vuyisich

Ankur Kalra, Momchilo Vuyisich,

Listen time: 45m 50s

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)
EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 5m 20s

Mohammed El-Sheikh, Nora Olsen El Caidi, Aginsha Kandiah, et al

Read time: 24m 35s

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s

Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al

Watch time: 15h 45m 20s (18 videos)
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s

James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al

Watch time: 1h 34m (7 videos)
Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
Heart Failure in Focus Podcast - Ep 6: Cardiorenal Care in Practice

Muthiah Vaduganathan, ,

Listen time: 20m 40s

Media

AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s

Nicolas M Van Mieghem

Watch time: 14m 12s (23 videos)
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s

Broadcast

Cardiovascular Renal Metabolic

Heart Failure
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano, Aaron Wong, et al

Watch time: 1h 3m 30s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar, Liesbeth van Rossum, et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
An Expert Approach to Cardio-Renal Protection in CKD: Part Two

James Burton, David Wheeler, Carol Pollock, et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
An Expert Approach to Cardio-Renal Protection in CKD: Part One

James Burton, David Wheeler, Carol Pollock, et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
AOM 2024

Harold Bays, Naveed Sattar, Mikhail Kosiborod, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2024 - Day 2

Antonio Ceriello, Ileana L Piña, Gianluigi Savarese, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2024 - Day 1

Antonio Ceriello, Ileana L Piña, Gianluigi Savarese, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
Optimising RAASi Management in Cardiorenal Patients

Andrew Frankel, Shelley Zieroth, Aaron Wong, et al

Watch time: 1h 7m 6s

Articles

Malnutrition and Prognosis in Elderly Patients with Chronic Heart Failure

Mohammed El-Sheikh

,

Nora Olsen El Caidi

,

Aginsha Kandiah

,

Sandra Henriette Tonning

,

Ida Arentz Taraldsen

,

Frederik Dencker Wisborg

,

Ove Andersen

,

Jens Dahlgaard Hove

,

Johannes Grand

,

Published:

20 October 2025

Citation:

Cardiac Failure Review 2025;11:e26.

DOI:

https://doi.org/10.15420/cfr.2025.31
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 220
  • Downloads: Downloads 22
  • Read time: 24m 35s

Aldosterone Synthase Inhibitors

Shubh K Patel

,

Hwee Teoh

,

Ahreni Saunthar

,

Terrence M Yau

,

Subodh Verma

,

Published:

18 August 2025

Citation:

Cardiac Failure Review 2025;11:e20.

DOI:

https://doi.org/10.15420/cfr.2025.09
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1009
  • Downloads: Downloads 101
  • Citations: 3
  • Read time: 24m 34s

Understanding the Role of GLP-1 RAs in the Treatment of HF

Giovanni Battista Bonfioli

,

Matteo Pagnesi

,

Daniela Tomasoni

,

Amina Rakisheva

,

Marco Metra

,

Published:

14 August 2025

Citation:

Cardiac Failure Review 2025;11:e19.

DOI:

https://doi.org/10.15420/cfr.2025.10
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 355
  • Downloads: Downloads 69
  • Read time: 15m 45s

Obesity, Cardiac MRI Structure and Non-ischaemic Cardiomyopathy

Long Peng

,

Tao Zeng

,

Enxi Quan

,

Shufang Pan

,

Bin Li

,

Zheqi Wen

,

Zhaojun Xiong

,

Yunyue Zhao

,

Published:

09 May 2025

Citation:

Cardiac Failure Review 2025;11:e10.

DOI:

https://doi.org/10.15420/cfr.2024.26
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 351
  • Downloads: Downloads 50
  • Read time: 21m 26s